LDX vs NYR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

LDX

LUMOS FPO [LDX]

52MEDIUM

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

Score Breakdown

LDX NYR
Technical
59
72
Catalyst
31
53
Sentiment
50
50
Fundamental
54
38
Momentum
79
71
Risk Gate
45
42

Key Metrics

LDX Metric NYR
$211.4MMarket Cap$134.7M
3.0MAvg Volume (20d)545K
N/AShort InterestN/A
$0.33052-Week High$1.435
$0.01952-Week Low$0.091
+8.2%Daily Change+16.9%
$0.265Entry Price$0.567
-123.3%ROE-71.0%
-75.8%Profit Margin-234.3%

Active Signals

LDX Signals

Stochastic just turned bullish from a low level — early reversal sign
Drifting lower — down 7.0% over the last 5 days
Trading above the 200-day average — the long-term trend is on your side
Adequate cash runway (5 quarters)
Piotroski F-Score weak (3/9, low-confidence approx)
EPS estimates revised downward (-10pts)
CANSLIM I: Institutional ownership (19%)
Deeply negative margins (-76%)

NYR Signals

MACD momentum is picking up steam
Stochastic just turned bullish from a low level — early reversal sign
Watch out — volume is flowing out even as price holds up. Distribution pattern
On a tear — up 12.3% over the last 5 days
Trading above the 200-day average — the long-term trend is on your side
Low cash runway (4 quarters) - dilution risk
Very high P/S ratio (56.6x)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare LDX and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
LDX Full Analysis → NYR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).